Search
Miami Oncology Summit: Oppenheimer's Head of Healthcare Investment Banking Michael Margolis discusses the funding environment and whether IPOs will pick back up
He says that the sector is much stronger than it was just months ago. Coverage brought to you by
Nov 6
BIO International 2025: Oppenheimer's Head of Healthcare Investment Banking, Michael Margolis, discusses biotech sentiment, M&A, and what it is like to raise money today
He describes how sentiment and the M&A environment have been improving, as well as some areas of the financing market. However, he...
Jun 17
Oppenheimer's Head of Healthcare Investment Banking shares his take on 2025 and highlights M&A, IPOs, and the ability of companies to raise money this year
Michael Margolis discusses the macro and policy factors that are in play this year, comments on the China factor, and describes how...
Feb 11
.png){kind=logo}
